Evidence map›Paper›PMID 40256671›Full record

ArticleBreast care (Basel, Switzerland)2025

Phyllodes Tumor of the Breast: Histomorphological Transformation to High-Grade Tumor during Pregnancy and Challenging Oncoplastic Surgery.

Caroline Ines Preuss, Peter Schrenk, Marco Affortunati, Nina Brandstetter, Stefanie Schuster, Heike Kathleen Schwarz, Bruno Schneeweiss, Thomas Gitter, Peter Oppelt, Andreas Shamiyeh and 4 more

Abstract read
In one paragraph

Article in Breast care (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Caroline Ines PreussDepartment of Gynaecology, Obstetrics and Gyn. Endocrinology, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria.
Peter SchrenkDepartment of General Surgery, Kepler University Hospital, Linz, Austria.
Marco AffortunatiDepartment of Gynaecology, Obstetrics and Gyn. Endocrinology, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria.
Nina BrandstetterDepartment of Gynaecology, Obstetrics and Gyn. Endocrinology, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria.
Stefanie SchusterDepartment of General Surgery, Kepler University Hospital, Linz, Austria.
Heike Kathleen SchwarzDepartment of Hematology and Internal Oncology, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria.
Bruno SchneeweissDepartment of Hematology and Internal Oncology, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria.
Thomas GitterDepartment of Radiology, Kepler University Hospital, Linz, Austria.
Peter OppeltDepartment of Gynaecology, Obstetrics and Gyn. Endocrinology, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria.
Andreas ShamiyehDepartment of General Surgery, Kepler University Hospital, Linz, Austria.
Rupert LangerClinical Institute of Pathology and Molecular Pathology, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria.
Farid MoinfarInstitute of Pathology und Molecular Pathology, Vincent Pathology Network, Ordensklinikum Linz (BHS), Linz, Austria.
Claudia GrosseClinical Institute of Pathology and Molecular Pathology, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria.
Maria SteinmairClinical Institute of Pathology and Molecular Pathology, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Phyllodes tumors of the breast are a very rare tumor entity. There are two different classifications according to AFIP (low-grade and high-grade phyllodes tumors of the breast) and WHO (three subtypes: benign, borderline, and malignant phyllodes tumors). Phyllodes tumors have an increased risk of recurrence. Primary clinical treatment of phyllodes tumors is surgery, although the width of the required resection margins often presents a challenge for surgical management. Case Presentation: This case report deals with a 24-year-old woman with second recurrence of borderline phyllodes tumor. The challenge of this case lays first in surgical removal of the large tumor by breast-conserving therapy with tumor-free margins and favorable aesthetic outcome. Achieving this goal by tumor-adapted reduction mammoplasty, skin excision, and slide-swing skin flap was challenging. The second exciting aspect of this case is the histomorphology of the tumor and the transformation in vivo from fibroadenoma with stromal atypia in 2021 to the first recurrence with a low-grade phyllodes tumor in 2022 and the further transformation to a high-grade tumor with stromal overgrowth in the second recurrence of phyllodes tumor in 2023 during pregnancy and childbed. Conclusion: This case of a phyllodes tumor shows how quickly tumor characteristics can change in fast-growing tumors due to transformation from low-grade to high-grade tumor. The influence of pregnancy on this process remains unclear at present. Surgical removal of phyllodes tumors should be performed during pregnancy.

Indexed as

Breast oncoplastic surgeryBreast sarcomaPhyllodes tumorPregnancyTumor transformation

Identifiers

PMID40256671
PMCPMC12005692

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.